Summary
A new hydroquinone compound, the internal salt of 2,5-bis-ethylenimino-hydroquinone, has a multiform antimitotic effect and a potent tumor-inhibiting action on a wide spectrum of inoculated tumors of mice and rats. On the other hand, normal tissues undergoing intensive cell division do not appear to be affected adversely from the histological standpoint.
Article PDF
Avoid common mistakes on your manuscript.
References
A. Marxer, Exper.11, 184 (1955).
F. E. Lehmann, Verh. Schweiz. Physiol.1942.
F. E. Lehmann undH. Hadorn, Helv. physiol. pharm. Acta4, 11 (1946).
R. Meier undM. Allgöwer, Exper.1, 57 (1945).
R. Meier undB. Schär, Exper.3, 358 (1947).
E. Friedmann, D. H. Marrian undI. Simon-Reuss, Brit. J. Pharmacol. Chemotherapy3, 263 (1948).
G. M. Badger, L. S. Elson, A. Haddow, C. L. Hewett undA. M. Robinson, Proc. Roy. Soc. [B],130, 255 (1941).
A. K. Powell, Brit. J. Cancer5, 264 (1951).
G. Domagk, S. Petersen undW. Gauss, Z. Krebsforschung59, 617 (1954).
B. Schär, P. Loustalot undF. Gross, Klin. Wschr.32, 49 (1954).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Loustalot, P., Schär, B. & Meier, R. Über antimitotische und tumorhemmende Eigenschaften des inneren Salzes des 2,5-Bis-Äthylenimino-hydrochinons. Experientia 11, 186 (1955). https://doi.org/10.1007/BF02161309
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02161309